Tech Company Financing Transactions
Dermavant Sciences Funding Round
On 6/8/2021, Dermavant Sciences announced $200 million in financing from Marathon Asset Management, NovaQuest and private investors.
Transaction Overview
Company Name
Announced On
6/8/2021
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$200,000,000
Round
Undisclosed
Investors
Marathon Asset Management (Steve DeNelsky)
NovaQuest (Brian Axe)
Proceeds Purpose
The company intends to use the funding proceeds for the payment of certain one-time milestone obligations that become payable upon the approval and commercialization of tapinarof for the treatment of psoriasis in the United States, as well as for other general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3780 Kilroy Airport Way 250
Long Beach, CA 90806
USA
Long Beach, CA 90806
USA
Phone
Undisclosed
Website
Email Address
Overview
Dermavant Sciences, a subsidiary of Roivant Sciences, is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant's focus is to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Zavodnick
Chief Financial Officer
Michael Swartzburg
Chief Medical Officer
Philip Brown
Chief Scientific Officer
David Rubenstein
Vice President
Kristopher Garcia
Vice President
Kenneth Peist
Vice President
Steve Piscitelli
Vice President
Paul Seaback
Vice President
Anna Tallman
Vice President
Diana Villalobos
VP - Bus. Development
Chris Chapman
VP - Bus. Development
Peter Nicholson
VP - Finance
Mark Luz
VP - General Counsel
Christopher Van Tuyl
VP - Regulatory Affairs
Elaine Clark
Browse more venture capital transactions:
Prev: 6/8/2021: Rae Wellness venture capital transaction
Next: 6/8/2021: Medallion venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs